These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Hardy J, Selkoe DJ. Science; 2002 Jul 19; 297(5580):353-6. PubMed ID: 12130773 [Abstract] [Full Text] [Related]
3. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, Yen SH, Sahara N, Skipper L, Yager D, Eckman C, Hardy J, Hutton M, McGowan E. Science; 2001 Aug 24; 293(5534):1487-91. PubMed ID: 11520987 [Abstract] [Full Text] [Related]
4. Biomedicine. Tauists and beta-aptists united--well almost! Lee VM. Science; 2001 Aug 24; 293(5534):1446-7. PubMed ID: 11520974 [No Abstract] [Full Text] [Related]
7. Pathogenesis of Alzheimer's disease and dementia. Bugiani O. Rev Neurol (Paris); 1999 Feb 21; 155 Suppl 4():S28-32. PubMed ID: 10637935 [Abstract] [Full Text] [Related]
8. [Neurofibrillary changes and phosphorylated tau of Alzheimer's disease]. Takeda M, Kudo T, Taniguchi N, Nishimura T. Nihon Ronen Igakkai Zasshi; 1996 Mar 21; 33(3):169-72. PubMed ID: 8648891 [No Abstract] [Full Text] [Related]
9. Alzheimer's disease. A new take on tau. Marx J. Science; 2007 Jun 08; 316(5830):1416-7. PubMed ID: 17556561 [No Abstract] [Full Text] [Related]
11. [Neurofibrillary tangles and early modification of the neuronal cytoskeleton in Alzheimer's disease and in experimental models]. Brion JP. Bull Mem Acad R Med Belg; 1999 Jul 08; 154(6 Pt 2):287-94. PubMed ID: 10992876 [Abstract] [Full Text] [Related]
12. Cytoskeletal abnormalities in Alzheimer's disease. Lovestone S, Anderton B. Curr Opin Neurol Neurosurg; 1992 Dec 08; 5(6):883-8. PubMed ID: 1467582 [Abstract] [Full Text] [Related]
13. [Pathogenesis of Alzheimer's disease]. Alegre M, Noé E, Luquin MR. Rev Med Univ Navarra; 1997 Dec 08; 41(1):46-57. PubMed ID: 9527714 [Abstract] [Full Text] [Related]
14. Molecular dissection of the neurofibrillary lesions of Alzheimer's disease. Goedert M, Spillantini MG, Hasegawa M, Jakes R, Crowther RA, Klug A. Cold Spring Harb Symp Quant Biol; 1996 Dec 08; 61():565-73. PubMed ID: 9246483 [No Abstract] [Full Text] [Related]
15. Tau and Alzheimer's disease: the long road to anti-tangle therapeutics. Fillit HM, Refolo LM. J Mol Neurosci; 2002 Dec 08; 19(3):249-50. PubMed ID: 12540049 [No Abstract] [Full Text] [Related]
16. Evolutional aspects of Alzheimer's disease pathogenesis. Braak H, Del Tredici K. J Alzheimers Dis; 2013 Dec 08; 33 Suppl 1():S155-61. PubMed ID: 22699850 [Abstract] [Full Text] [Related]
17. Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease. Jellinger KA, Attems J. Acta Neuropathol; 2007 Feb 08; 113(2):107-17. PubMed ID: 17089134 [Abstract] [Full Text] [Related]
18. Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease. Williams S, Chalmers K, Wilcock GK, Love S. Neuropathol Appl Neurobiol; 2005 Aug 08; 31(4):414-21. PubMed ID: 16008825 [Abstract] [Full Text] [Related]
19. Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging? Swerdlow RH. Neurobiol Aging; 2007 Oct 08; 28(10):1465-80. PubMed ID: 16876913 [Abstract] [Full Text] [Related]
20. Alzheimer's disease and amyloid. Robertson M. Nature; 1992 Mar 12; 356(6365):103. PubMed ID: 1545855 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]